Non-alcoholic fatty liver disease is characterised by a reduced polyunsaturated fatty acid transport via free fatty acids and high-density lipoproteins (HDL)

被引:21
|
作者
Mocciaro, Gabriele [1 ,2 ]
Allison, Michael [3 ]
Jenkins, Benjamin [4 ]
Azzu, Vian [3 ,4 ]
Huang-Doran, Isabel [3 ]
Herrera-Marcos, Luis Vicente [5 ]
Hall, Zoe [6 ]
Murgia, Antonio [1 ,4 ]
Susan, Davies [3 ,4 ]
Frontini, Mattia [7 ]
Vidal-Puig, Antonio
Koulman, Albert [4 ]
Griff, Julian L. [1 ,8 ]
Vacca, Michele [1 ,2 ,4 ,9 ,10 ]
机构
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England
[2] Fdn Liver Res, Roger Williams Inst Hepatol, London SE5 9NT, England
[3] Addenbrookes Hosp, Cambridge Biomed Res Ctr, Dept Med, Cambridge, England
[4] Wellcome Trust MRC Inst Metab Sci, Metab Res Labs, Cambridge CB2 0QQ, England
[5] Univ Zaragoza, Vet Fac, Dept Biochem & Mol & Cellular Biol, Zaragoza 50013, Spain
[6] Imperial Coll London, Dept Metab Digest & Reprod, Div Syst Med, Biomol Med, London SW7 2AZ, England
[7] Univ Exeter, Fac Hlth & Life Sci, Clin & Biomed Sci, Med Sch, RILD Bldg,Barrack Rd, Exeter EX2 5DW, England
[8] Univ Aberdeen, Rowett Inst, Foresterhill Campus, Aberdeen AB25 2ZD, Scotland
[9] Aldo Moro Univ Bari, Dept Interdisciplinary Med, Clin Med C Frugoni, I-70124 Bari, Italy
[10] Aldo Moro Univ Bari, Dept Interdisciplinary Med, Clin Med C Frugoni, I-70124 Bari, Italy
来源
MOLECULAR METABOLISM | 2023年 / 73卷
基金
英国医学研究理事会;
关键词
Non-alcoholic fatty liver disease (NAFLD); Obesity; Lipoprotein metabolism; Lipidomics; LC-MS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; CHOLESTEROL EFFLUX; HEPATIC STEATOSIS; SCORING SYSTEM; METABOLISM; MARKERS; PHOSPHATIDYLCHOLINE; TRIACYLGLYCEROL; SPHINGOMYELIN;
D O I
10.1016/j.molmet.2023.101728
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Non-alcoholic fatty liver disease (NAFLD) develops due to impaired hepatic lipid fluxes and is a risk factor for chronic liver disease and atherosclerosis. Lipidomic studies consistently reported characteristic hepatic/VLDL "lipid signatures" in NAFLD; whole plasma traits are more debated. Surprisingly, the HDL lipid composition by mass spectrometry has not been characterised across the NAFLD spectrum, despite HDL being a possible source of hepatic lipids delivered from peripheral tissues alongside free fatty acids (FFA). This study characterises the HDL lipidomic signature in NAFLD, and its correlation with metabolic and liver disease markers.Methods: We used liquid chromatography-mass spectrometry to determine the whole serum and HDL lipidomic profile in 89 biopsy-proven NAFLD patients and 20 sex and age-matched controls. Results: In the whole serum of NAFLD versus controls, we report a depletion in polyunsaturated (PUFA) phospholipids (PL) and FFA; with PUFA PL being also lower in HDL, and negatively correlated with BMI, insulin resistance, triglycerides, and hepatocyte ballooning. In the HDL of the NAFLD group we also describe higher saturated ceramides, which positively correlate with insulin resistance and transaminases.Conclusion: NAFLD features lower serum lipid species containing polyunsaturated fatty acids; the most affected lipid fractions are FFA and (HDL) phospholipids; our data suggest a possible defect in the transfer of PUFA from peripheral tissues to the liver in NAFLD. Mechanistic studies are required to explore the biological implications of our findings addressing if HDL composition can influence liver metabolism and damage, thus contributing to NAFLD pathophysiology.(c) 2023 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Non-Alcoholic Fatty Liver Disease
    Engin, Atilla
    OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
  • [22] Non-alcoholic fatty liver disease
    Brent A. Neuschwander-Tetri
    BMC Medicine, 15
  • [23] Non-alcoholic fatty liver disease
    Alba, LM
    Lindor, K
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
  • [24] Non-alcoholic fatty liver disease
    Bjornsson, Einar
    Angulo, Paul
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (09) : 1023 - 1030
  • [25] Non-alcoholic fatty liver disease
    Cua, IHY
    George, J
    HOSPITAL MEDICINE, 2005, 66 (02): : 106 - 111
  • [26] Non-alcoholic fatty Liver disease
    Calderaro, Julien
    Zafrani, Elie Serge
    ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
  • [27] Non-alcoholic fatty liver disease
    Farrell, Geoffrey C.
    Wardell, Rebecca
    Teoh, Narci
    Chitturi, Shiv
    INTERNAL MEDICINE JOURNAL, 2019, 49 (05) : 681 - 683
  • [28] Non-alcoholic fatty liver disease
    Adams, LA
    Angulo, P
    LIVER DISEASES: ADVANCES IN TREATMENT AND PREVENTION: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 137 : 250 - 270
  • [29] Non-alcoholic fatty liver disease
    Sattar, Naveed
    Forrest, Ewan
    Preiss, David
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 349
  • [30] Non-alcoholic fatty liver disease
    Li, Wenhao
    Alazawi, William
    CLINICAL MEDICINE, 2020, 20 (05) : 509 - 512